Folfirinox versus gemcitabine/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study
暂无分享，去创建一个
D. Pezet | J. Taieb | D. Tougeron | S. Pernot | N. Williet | J. Phelip | P. Artru | J. Desramé | B. Le Roy | V. Hautefeuille | D. Béchade | I. Trouilloud | C. Locher | N. Lourenço | A. Pozet | A. Thirot Bidault | Anne-Laure Pointet | A. Saint